Inactive/Delisted stock
Creative Medical Technology Stock (NASDAQ:CELZ)
Previous Close
$3.07
52W Range
$1.69 - $6.90
50D Avg
$2.73
200D Avg
$2.80
Market Cap
$8.05M
Avg Vol (3M)
$149.81K
Beta
4.93
Div Yield
-
CELZ Company Profile
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.